Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants
Autore:
Stough, C; Clarke, J; Lloyd, J; Nathan, PJ;
Indirizzi:
Swinburne Univ Technol, Neuropsychol Lab BSEE, Hawthorn, Vic 3122, Australia Swinburne Univ Technol Hawthorn Vic Australia 3122 n, Vic 3122, Australia Swinburne Univ Technol, Brain Sci Inst, Neuropharmacol Lab, Melbourne, Vic, Australia Swinburne Univ Technol Melbourne Vic Australia Melbourne, Vic, Australia
Titolo Testata:
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
fascicolo: 2, volume: 4, anno: 2001,
pagine: 131 - 134
SICI:
1461-1457(200106)4:2<131:NCA3GB>2.0.ZU;2-U
Fonte:
ISI
Lingua:
ENG
Soggetto:
EXTRACT EGB 761; BRAIN;
Keywords:
Ginkgo biloba; intelligence; nootropic agents; working memory; speed of information processing;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
11
Recensione:
Indirizzi per estratti:
Indirizzo: Stough, C Swinburne Univ Technol, Neuropsychol Lab BSEE, POB 218, Hawthorn, Vic 3122, Australia Swinburne Univ Technol POB 218 Hawthorn Vic Australia3122 ralia
Citazione:
C. Stough et al., "Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants", IN J NEUROP, 4(2), 2001, pp. 131-134

Abstract

Ginkgo biloba extract (EGb) from the world's oldest living tree has been reputed to ameliorate cognitive decline in the elderly and slow cognitive deterioration in patients with dementia of the Alzheimer's type. EGb remains as one of the most popular plant extracts to alleviate symptoms associated with a range of cognitive disorders such as Alzheimer's disease, vascular dementia and age-related amnesic conditions. EGb is known to contain a rangeof chemically active components that have antagonistic effects on platelet-activating factor, free-radical scavenging activity and direct effects on the cholinergic neurotransmitter system. Recently there has been much speculation, that EGb may act as a 'smart drug' or nootropic agent in the healthy young to improve intelligence. We conducted a 30-d randomized, double-blind, placebo-controlled clinical trial in which 61 participants were administered a battery of validated neuropsychological tests before and after treatment. Statistical analysis indicated significant improvements in speed of information processing working memory and executive processing attributableto the EGb.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/20 alle ore 21:03:11